Related Articles
Repression of the expression of TET2 by ZEB1 contributes to invasion and growth in glioma cells
Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency. Corrigendum in /10.3892/ol.2020.11907
Epigenetic aberrations in myeloid malignancies (Review)
IDH2 compensates for IDH1 mutation to maintain cell survival under hypoxic conditions in IDH1‑mutant tumor cells
Absence of R140Q mutation of isocitrate dehydrogenase 2 in gliomas and breast cancers